Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Renal Denervation Researcher Argues Sham Control Is Ethically Necessary

This article was originally published in The Gray Sheet

Executive Summary

The lead investigator on the SYMPLICITY HTN-3 trial says sham-controlled trials are sometimes ethically necessary to prevent patients from undergoing ineffective treatments and warns there may be other medical devices on the market that are not as effective as previously thought.


Related Content

Q&A: Mark McClellan Discusses Gottlieb, Cures And More
FDA Confirmation Watch: Gottlieb Likely To Face Questions About Approval Standards, Ties To Industry
Gottlieb At FDA: Industry Will Look For User-Fee Deal Support, Restrained Regulations
Editors' Picks: Six Themes From 2014
ReShape Duo Delivers Weight Loss In Sham-Controlled Pivotal Trial
Finding A Future For Renal Denervation With Better Controlled Trials
Symplicity Makes Life Difficult For Renal Denervation Programs
FDA Articulates Design Principles For Pivotal Trials In Final Guidance
TMR + CABG Trial Data Reveal Little About Procedure’s Efficacy – MCAC
Are Placebo Trials a Wave of the Future in Medical Devices?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts